Composition and changes in breast cancer patients' diagnosis and treatment expenses under the influence of medical insurance policy reform-A study on 3 950 patients in Guangxi Medical University Cancer Hospital. / åŒ»ä¿æ”¿ç­–æ”¹é©å½±å“ä¸‹ä¹³è ºç™Œæ‚£è€ è¯Šç–—è´¹ç”¨çš„æž„æˆåŠå˜åŒ–­­åŸºäºŽå¹¿è¥¿åŒ»ç§‘大学附属肿瘤医院3 950ä¾‹æ‚£è€ çš„ç ”ç©¶.

ABSTRACT

OBJECTIVES: To understand the influence of medical insurance policy reforms in Guangxi on the hospitalization expenses of breast cancer patients by analyzing the composition and changing trend in breast cancer diagnosis and treatment expenses in the Guangxi Medical University Cancer Hospital, and to provide the evidence for the improvement of medical insurance policy reform. METHODS: A total of 3 950 breast cancer patients were collected from 2014 to 2017 and analyzed. Kruskal-Wallis test and multiple linear regression model were used to discuss the breast cancer related epidemiology and analyze the composition of hospitalization expenses and its influential factors. RESULTS: The median hospitalization cost of breast cancer patients in our hospital from 2014 to 2017 was 29 266.94 Chinese Yuan. Single factor analysis showed that the impact of year, hospitalization days, age, payment method, tumor stage, and treatment method on hospitalization cost was significant (all P<0.01). Multiple linear regression analysis showed that the power of influential factors of hospitalization costs arranged descending from 2014 to 2017 as follows hospitalization days, treatment methods, payment method, tumor staging, and age. CONCLUSIONS: Reasonably controlling hospitalization days and actively promoting the integration of urban and rural medical insurance can effectively reduce the economic burden for breast cancer patients.